DSS curves of independent parameters in patients with transformed MF. (A) Curves for total group of patients with transformed MF (n = 100), indicating CD30 expression, folliculotropic MF (FMF), extent of skin lesions, and clinical stage, respectively. (B) Curves for subanalysis of patients with only skin lesions and LCT (n = 75), indicating CD30 expression, FMF and extent of skin lesions. * indicates number of persons at risk at the specified times after diagnosis of transformed MF.